Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. But the reality is that when a company ...
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. But as Peter Lynch said ...
Antares Pharma (NASDAQ:ATRS) releases its next round of earnings this Tuesday, March 02. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report. What Are Earnings ...
Antares ( ATRS) has fallen 27% from its closing price of $5.30 on July 16 to a recent closing price of $3.88 on September 7. Price behavior like this can presage problems and gives cause for investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback